Fazla Kilolu ve Obez Bireylerde Kardiyovasküler Risk Faktörlerinin Kontrolünde Diyetin Etkinliği

Year 2026, Volume: 18 Issue: 1 , 34 - 44 , 28.04.2026

Eda Türe , Ertan Mert

https://izlik.org/JA54YD58PW

Abstract

Amaç: Bu çalışmanın amacı, fazla kilolu ve obez bireylerde uygulanan standardize edilmiş, kişiye uyarlanmış diyet müdahalesinin kardiyovasküler risk faktörleri ve Framingham risk skoru ile hesaplanan 10 yıllık kardiyovasküler hastalık (KVH) riski ile ilişkisini değerlendirmektir.
Gereç ve Yöntem: Prospektif ve müdahale temelli olarak planlanan bu çalışma, Ocak–Ağustos 2013 tarihleri arasında bir üniversite hastanesinin aile hekimliği kliniğinde yürütülmüştür. Çalışmaya vücut kitle indeksi ≥25 kg/m² olan 205 birey (178 kadın, 27 erkek) dahil edilmiştir. Katılımcılara altı ay süreyle standardize edilmiş, kişiye uyarlanmış diyet programı uygulanmıştır. Müdahale öncesi ve sonrasında vücut kitle indeksi (VKİ), bel çevresi, kan basıncı, açlık kan şekeri, Hemoglobin A1c (HbA1c), total kolesterol, LDL, HDL ve trigliserid düzeyleri değerlendirilmiştir. On yıllık KVH riski Framingham risk skoru kullanılarak hesaplanmıştır. Diyet öncesi ve sonrası ölçümler eşleştirilmiş gruplarda paired-samples t testi ile karşılaştırılmıştır.
Bulgular: Diyet müdahalesi sonrasında VKİ, bel çevresi, kan basıncı, glisemik ve lipit parametrelerinde istatistiksel olarak anlamlı olmayan ancak klinik açıdan olumlu kabul edilebilecek iyileşme eğilimleri izlenmiştir. Kadınlarda HbA1c ≥6,5 oranı %25’ten %10’a, erkeklerde %50’den %40,9’a gerilemiştir. Evre 1 hipertansiyon oranı kadınlarda %22,5’ten %7,3’e, erkeklerde %33,3’ten %11,1’e düşmüştür. En belirgin ve istatistiksel olarak anlamlı bulgu, Framingham risk skorundaki azalmadır (p<0,05). Kadınlarda en belirgin düşüş 60–64 yaş grubunda (%−2,4), erkeklerde 65–69 yaş grubunda (%−2,8) saptanmıştır. Başlangıçta tüm katılımcıların üçte birinde (%33,2) kronik hastalık, %27,8’inde aktif sigara kullanımı mevcuttu; bu risk faktörleri Framingham skorlamasında belirleyici olmuştur.
Sonuç: Bu çalışmada, standardize edilmiş ve kişiye uyarlanmış diyet müdahalesi sonrasında kardiyometabolik risk göstergelerinde değişim eğilimleri ve Framingham risk skorunda anlamlı bir azalma ile ilişki saptanmıştır. Ancak kontrol grubunun bulunmaması nedeniyle gözlenen değişikliklerin yalnızca diyet müdahalesine atfedilmesi mümkün değildir. Bulgular, fazla kilolu ve obez bireylerde beslenme temelli müdahalelerin kardiyovasküler risk profilinde iyileşme eğilimi ile ilişkili olabileceğini düşündürmektedir. Bu alanda nedensel ilişkilerin ortaya konulabilmesi için kontrollü ve uzun süreli çalışmalara ihtiyaç vardır.

Keywords

obezite , kalp ve damar hastalıkları , risk faktörleri , diyet

Ethical Statement

Çalışma, Mersin Üniversitesi Tıp Fakültesi Tıbbi Araştırmalar Etik Kurulu’nun 19.07.2012 tarihli ve 2012/256 numaralı onayı ile yürütüldü. Çalışma yapılırken Helsinki Bildirgesi ilkelerine uygun hareket edilmiştir.

Supporting Institution

Bu araştırma herhangi bir fonlama kuruluşu/sektöründen hibe almamıştır.

Thanks

Yazarlar, Mersin Üniversitesi Tıp Fakültesi Aile Hekimliği Anabilim Dalı çalışanlarına araştırma sürecindeki destekleri için teşekkür etmektedir.

Effectiveness of Diet in Controlling Cardiovascular Risk Factors in Overweight and Obese Individuals

https://izlik.org/JA54YD58PW

Abstract

Objective: The objective of this study is to evaluate the relationship between a standardized, individualized dietary intervention applied to overweight and obese individuals and cardiovascular risk factors and the 10-year cardiovascular disease (CVD) risk calculated using the Framingham risk score.
Materials and Methods: This prospective, intervention-based study was conducted at a university hospital's family medicine clinic between January and August 2013. A total of 205 individuals (178 women, 27 men) with a body mass index (BMI) ≥25 kg/m² were included in the study. Participants were assigned to a standardized, personalized diet program for six months. Body mass index (BMI), waist circumference, blood pressure, fasting blood glucose, hemoglobin A1c (HbA1c), total cholesterol, LDL, HDL, and triglyceride levels were assessed before and after the intervention. Ten-year CVD risk was calculated using the Framingham risk score. Pre- and post-diet measurements were compared in matched groups using the paired-samples t-test.
Results: Following dietary intervention, trends toward improvement were observed in BMI, waist circumference, blood pressure, glycemic, and lipid parameters, which were not statistically significant but could be considered clinically favorable. The proportion of women with HbA1c ≥6.5 decreased from 25% to 10%, and in men from 50% to 40.9%. The prevalence of stage 1 hypertension decreased from 22.5% to 7.3% in women and from 33.3% to 11.1% in men. The most prominent and statistically significant finding was the decrease in the Framingham risk score (p<0.05). The most significant decrease was observed in the 60–64 age group in women (−2.4%) and in the 65–69 age group in men (−2.8%). At baseline, one-third of all participants (33.2%) had chronic disease, and 27.8% were active smokers; these risk factors were decisive in the Framingham scoring.
Conclusion: In this study, trends in changes in cardiometabolic risk indicators and a significant decrease in the Framingham risk score were found to be associated with standardized and personalized dietary interventions. However, due to the absence of a control group, it is not possible to attribute the observed changes solely to the dietary intervention. The findings suggest that nutrition-based interventions may be associated with an improvement trend in the cardiovascular risk profile of overweight and obese individuals. Controlled and long-term studies are needed to establish causal relationships in this area.

Keywords

obesity , cardiovascular diseases , risk factors , diet

Ethical Statement

The study was conducted with the subscription of Mersin University Faculty of Medicine Medical Research Ethics Committee dated 19.07.2012 and numbered 2012/256.

Supporting Institution

This research has not received any grants from any funding organization/sector.

Thanks

The authors would like to thank the staff of Mersin University Faculty of Medicine, Department of Family Medicine, for their support during the research process.

References

• Referans 1. World Health Organization. Obesity and overweight. Geneva: World Health Organization; 2023.
• Referans 2. Türkiye Cumhuriyeti Sağlık Bakanlığı. Türkiye Beslenme ve Sağlık Araştırması 2023. Ankara: T.C. Sağlık Bakanlığı Yayınları; 2023.
• Referans 3. Türk Kardiyoloji Derneği. Türkiye Kalp Sağlığı Raporu 2024. İstanbul: Türk Kardiyoloji Derneği Yayınları; 2024.
• Referans 4. Çubukçu M, Türe E, Yazıcıoğlu B, Yavuz E. The Relationship of Vitamin D Status with Body Mass Index Among Obese Patients Registered to the Obesity Center. Turk J Fam Pract. 2021;25(2):47-52.
• Referans 5. Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.
• Referans 6. Aune D, Sen A, Prasad M, Norat T, Janszky I, Tonstad S, et al. BMI and all-cause mortality: systematic review and non-linear dose–response meta-analysis of 230 cohort studies. BMJ. 2016;353:2156.
• Referans 7. Özsu E, Yazıcıoğlu B. Relationship Between Obesity and Platelet Indices in Children. Cukurova Medical Journal. 2018;43(1):30-35.
• Referans 8. Özsu E, Yazıcıoğlu B. Obese boys with low concentrations of high-density lipoprotein cholesterol are at greater risk of hepatosteatosis. Hormones. 2019;18:477–484.
• Referans 9. Perone F, Spadafora L, Pratesi A, Nicolaio G, Pala B, Franco G, et al. Obesity and cardiovascular disease: risk assessment, physical activity, and management of complications. Int J Cardiol Cardiovasc Risk Prev. 2024;23:200331.
• Referans 10. Mahdavi A, Mohammadi H, Foshati S, Shokri-Mashhadi N, Clark CCT, Moafi A, et al. Effects of the DASH diet on blood pressure, glucose, and lipid profile in adolescents with hemophilia: a randomized clinical trial. Food Sci Nutr. 2021;9(1):145–153.
• Referans 11. U.S. Department of Health and Human Services; National Heart, Lung, and Blood Institute. Your guide to lowering blood pressure with DASH. Washington (DC): National Institutes of Health; 2006.
• Referans 12. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279–1290.
• Referans 13. Mansoor N, Vinknes KJ, Veierød MB, Retterstøl K. Effects of low-carbohydrate versus low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Br J Nutr. 2016;115(3):466–479.
• Referans 14. Kolivas D, Fraser L, Schweitzer R, Brukner P, Moschonis G. mHealth low-carbohydrate dietary intervention improves glycaemia, blood pressure and weight in type 2 diabetes. NPJ Metab Health Dis. 2025;3(1):12.
• Referans 15. Bermingham KM, Linenberg I, Polidori L, Asnicar F, Arrè A, Wolf J, et al. Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial. Nat Med. 2024;30(7):1888–1897.
• Referans 16. D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–753.
• Referans 17. Gibbs BB, King WC, Belle SH, Jakicic JM. Six-month changes in ideal cardiovascular health versus Framingham risk among young adults enrolled in a weight loss intervention. Prev Med. 2016;86:123–129.
• Referans 18. Wanders L, Gijbels A, Hul GB, Feskens EJM, Afman LA, Blaak EE, et al. Impact of a 12-week personalized dietary intervention on vascular function and cardiovascular risk factors. Diabetes Obes Metab. 2025;27(5):2601–2612.
• Referans 19. Kivimäki M, Strandberg T, Pentti J, Nyberg ST, Frank P, Jokela M, et al. Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study. Lancet Diabetes Endocrinol. 2022;10(4):253–263.
• Referans 20. Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143(21):e984–e1010.
• Referans 21. Valenzuela PL, Carrera-Bastos P, Castillo-García A, et al. Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol. 2023;20(7):475–494.
• Referans 22. Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020;16(3):177–189.
• Referans 23. Filippou CD, Tsioufis CP, Thomopoulos CG, Mihas CC, Dimitriadis KS, Sotiropoulou LI, et al. Dietary Approaches to Stop Hypertension (DASH) diet and blood pressure reduction in adults with and without hypertension: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2020;11(5):1150–1160.
• Referans 24. Filippou C, Tatakis F, Polyzos D, Manta E, Thomopoulos C, Nihoyannopoulos P, et al. Overview of salt restriction in the DASH and Mediterranean diets for blood pressure reduction. Rev Cardiovasc Med. 2022;23(1):36.
• Referans 25. Aljuraiban GS, Gibson R, Chan DS, Van Horn L, Chan Q. The role of diet in the prevention of hypertension and management of blood pressure: an umbrella review of meta-analyses. Adv Nutr. 2024;15(1):100123.
• Referans 26. Lari A, Sohouli MH, Fatahi S, Cerqueira HS, Santos HO, Pourrajab B, et al. Effects of the DASH diet on metabolic risk factors in patients with chronic disease: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2021;31(10):2766–2778.
• Referans 27. Anagnostou A, Larumbe-Zabala E, Fiore J, Roberts J, Naclerio F. Effects of energy-matched low- versus high-carbohydrate diets on glycaemic control, lipid profile and body composition: a systematic review and meta-analysis. Eur J Nutr. 2026;65(1):19.
• Referans 28. Marume A, Chidoko E, Chirenda J. Dietary interventions and glycaemic control in type 2 diabetes: a systematic review and meta-analysis. J Public Health Afr. 2025;16(1):1325.
• Referans 29. Rajaguru V, Kim J, Chapagain DD, Kim TH, Lee SG, Han WM. Low-carbohydrate diet and metabolic syndrome risk in Korean adults: a KNHANES study. Nutrients. 2026;18(1):178.
• Referans 30. Gomez-Garcia C, Maher CA, Sañudo B, Jurado-Castro JM. Mobile health interventions for individuals with type 2 diabetes and overweight or obesity: a systematic review and meta-analysis. J Funct Morphol Kinesiol. 2025;10(3):292.
• Referans 31. Feingold KR. The effect of diet on cardiovascular disease and lipid and lipoprotein levels. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2024.
• Referans 32. Chen X, Zhang X, Xiang X, Fang X, Wei F, Feng S. Effects of weight control interventions on cardiovascular outcomes: an umbrella review of systematic reviews and meta-analyses. Int J Obes (Lond). 2025;49(10):1911–1920.
• Referans 33. Hernando-Redondo J, Hernáez Á, Sanllorente A, et al. Mediterranean diet modulates gene expression of cholesterol efflux receptors in high-risk cardiovascular patients. Mol Nutr Food Res. 2025;69(13):e70050.
• Referans 34. Abdollahpour N, Seifi N, Nosrati M, Esmaily H, Shahri AMM, Ferns GA, et al. Comparative effects of intermittent fasting and calorie restriction on cardiovascular health in adults with overweight or obesity. Sci Rep. 2025;16(1):2867.
• Referans 35. Ahmadijoo P, Eftekhari MH, Masoumi SJ, Zahedani MR, Mohammadi F. The possible relationship between the Healthy Eating Index-2015 and the 10-year risk of cardiovascular diseases. BMC Nutr. 2023;9(1):76.
• Referans 36. Bouzas C, Bibiloni MDM, Garcia S, et al; PREDIMED-Plus Investigators. Desired weight loss and its association with health, health behaviors and perceptions in adults with excess weight: one-year follow-up. Front Nutr. 2022;9:848055.
• Referans 37. Williams KA, Fughhi I, Fugar S, et al. Nutrition intervention for reduction of cardiovascular risk using ACC/AHA primary prevention guidelines. Nutrients. 2021;13(10):3422.
• Referans 38. Banck MA, Bernhart SH, Müller L, et al. Associations between lifestyle, malnutrition, and health risks in a comprehensive population-based analysis. Sci Rep. 2025;15(1):44222.